University of Bristol - Explore Bristol Research

Similar documents
Vascular Dementia. Laura Pedelty, PhD MD The University of Illinois at Chicago and Jesse Brown VA Medical Center

Small Vessel Disease and Dementia:

Cerebral small vessel disease

Form D1: Clinician Diagnosis

September 26 28, 2013 Westin Tampa Harbour Island. Co-sponsored by

Patient with vertigo, dizziness and depression

The state of play in vascular dementia research: a lay summary 1. Introduction

Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer s disease

Research Article Behavioural and Psychological Symptoms in Poststroke Vascular Cognitive Impairment

stroke.org.uk Lay Summary:

Silent Cerebral Strokes: Clinical Outcomes and Management

Cerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11

POST STROKE DEMENTIA: DIAGNOSIS & INTERVENTION. Danielle E. Eagan, Ph.D. Barrow Neurological Institute Stroke Symposium October 13, 2018

NAME: DATE: SCHOOL/ORGANISATION:

The role of the vascular system in dementia

Patterns of Cognitive Impairment in Dementia

Health Learning Partnership 13 th September Neuroimaging. Headache Dementia Incidentalomas DR MARCUS BRADLEY CONSULTANT NEURORADIOLOGIST

VASCULAR COGNITIVE IMPAIRMENT/DEMENTIA SETTING THE STAGE

Patterns of Cognitive Impairment in Dementia

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

Neuroimaging for dementia diagnosis. Guidance from the London Dementia Clinical Network

Assessment at the bedside or in the clinic using the history, examination and laboratory tests to distinguish between different types of dementia

Is PET/CT really helpful in diagnosing Alzheimer s Disease?

MRI of Pathological Aging Brain

Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease

Next patient please Dementia Clare Hawley 2018

Neuropathology lecture series. III. Neuropathology of Cerebrovascular Disease. Physiology of cerebral blood flow

If searching for a book Vascular Dementia in pdf format, then you've come to the correct site. We furnish utter version of this ebook in doc, DjVu,

Delirium & Dementia. Nicholas J. Silvestri, MD

Non Alzheimer Dementias

HYPERTENSIVE ENCEPHALOPATHY

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)

Dementia and Healthy Ageing : is the pathology any different?

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

CADASIL: structural MR imaging changes and apolipoprotein E genotype S E V E N

AHA/ASA Scientific Statement

Diagnosing vascular cognitive impairment and dementia: concepts and controversies

Consensus statement for diagnosis of subcortical small vessel disease

Consensus statement for diagnosis of subcortical small vessel disease

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge

Title: Translational Models for Vascular Cognitive Impairment. A Review Including Larger Species

Re: Request for Information: Updating the Alzheimer s Disease-Related Dementias Research Priorities

Cerebrovascular Disease

ARIC V5 / NCS Code Book III, S.5. Section 5: Derived Variable File

Characterizing cerebral small vessel disease with a focus on CADASIL as a genetic model -an MRI based approach

SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY

CNS pathology Third year medical students. Dr Heyam Awad 2018 Lecture 7: Non traumatic brain haemorrhage

Mild Cognitive Impairment (MCI)

Interactive Cases: Demyelinating Diseases and Mimics. Disclosures. Case 1 25 yo F with nystagmus; look for tumor 4/14/2017

Neuropathology autopsy practice: Post-mortem examination in cerebrovascular disease (stroke) DRAFT November 2011

Brain Health and Risk Factors for Dementia

As life span rises, dementia has become a growing public. Stroke Compendium. Vascular Cognitive Impairment. Circulation Research Compendium on Stroke

University of Bristol - Explore Bristol Research

Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia

Moving Targets: An Update on Diagnosing Dementia in the Clinic

Atherosclerosis Risk in Communities Study. NCS Stages 2/3. DERIVED VARIABLE DICTIONARY DERIVE_NCS51 SAS DATASET VERSION 51 October 2016

UDS version 3 Summary of major changes to UDS form packets

Common Versus Uncommon Causes of Dementia

UNIVERSITY OF WESTERN ONTARIO

Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE

Contents 1 Normal Histology and Commonly Used Stains 2 Basic Pathologic Reactions

Vessel Wall Imaging of Intracranial Arterial Disease Commercial Interests

Case 9511 Hypertensive microangiopathy

김광일 서울대학교의과대학내과학교실 분당서울대학교병원내과

Cerebrovascular diseases-2

What is the appropriate evaluation of cryptogenic stroke, and when is a hypercoagulability work-up needed? David E. Thaler, MD, PhD, FAHA

T he concept of vascular cognitive covers a

JUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012

Regulatory Challenges across Dementia Subtypes European View

Brain imaging for the diagnosis of people with suspected dementia

Contents. How to Use This Book? General Background Main Classification System A Route-Map or Classification Tree...

Dementia and Delirium

A Case of Vascular MCI

Secondary Prevention of. Stroke: What a GP needs to know

Vascular Cognitive Impairment

A common clinical dilemma. Ischaemic stroke or TIA with atrial fibrillation MRI scan with blood-sensitive imaging shows cerebral microbleeds

CEREBROVASCULAR DISEASES. By: Shifaa AlQa qa

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people

Recent publications using the NACC Database. Lilah Besser

Learning Outcomes. To have a clear understanding of the term dementia, and current facts and statistics relating to dementia.

PRESERVE: How intensively should we treat blood pressure in established cerebral small vessel disease? Guide to assessing MRI scans

Vascular burden of the white matter.

Downloaded from Binswanger s Disease. Binswanger s Disease

Vascular Cognitive Impairment-- NEUROPATHOLOGIC ISSUES. VCI vs. IVD/DEMENTIA with VASCULAR DISEASE (IVD) advanced pathology

Geriatric Grand Rounds

SUBSPECIALTY CERTIFICATION EXAMINATION IN VASCULAR NEUROLOGY Content Blueprint (December 8, 2017)

Preliminary evaluation on cerebral small vascular disease with cerebral arerio-venous pulse wave time

Turkish Title: Akut Eş Zamanlı Subkortikal Infarktların Neden Olduğu Progresif Bulber Paralizi ile Prezente olan CADASIL Olgusu

brain MRI for neuropsychiatrists: what do you need to know

Leukoaraiosis new concepts and modern imaging

Why should white matter changes be taken into account; the clinical dementia perspective

Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective

Mild Cognitive Impairment

Following the health of half a million participants

21/05/2018. Today s webinar will answer. Presented by: Valorie O Keefe Consultant Psychologist

Guidelines for management of stroke in childhood

62 yo F, RHD Epilepsy onset: 44 yo Seizure type: 1) Dyscognitive seizure 2) Somatosensory aura (abnormal feeling at both feet) Seizures disappeared

Genetic Testing of CADASIL Syndrome. Populations Interventions Comparators Outcomes Individuals: With suspected CADASIL syndrome.

Transcription:

Skrobot, O. A., O'Brien, J., Black, S., Chen, C., DeCarli, C., Erkinjuntti, T.,... Kehoe, P. G. (2016). The vascular impairment of cognition classification consensus study. Alzheimer's and Dementia. DOI: 10.1016/j.jalz.2016.10.007 Peer reviewed version License (if available): CC BY-NC-ND Link to published version (if available): 10.1016/j.jalz.2016.10.007 Link to publication record in Explore Bristol Research PDF-document This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Elsevier at http://www.sciencedirect.com/science/article/pii/s1552526016330734. Please refer to any applicable terms of use of the publisher. University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/pure/about/ebr-terms

1. Be broad and capture forms of vascular- or cerebrovascular-related damage that are likely to contribute to cognitive impairment or dementia. 2. Address shortcomings in both mild and severe forms of vascular cognitive impairment and means to assess the transition of patients from one stage to another. 3. Recognise the importance of people who are at risk of VCI, however, their consideration under this construct should be contingent upon some level of impairment. 4. Acknowledge that the classification of a patient with a mild form of VCI (i.e. non-dementia) is not necessarily predictive of progression of the impairment to a more severe form of VCI (i.e. dementia). 5. Acknowledge that the classification of a patient with a mild form of VCI (i.e. non-dementia) is not necessarily predictive of an eventual sub-type of dementia. Box 1: VICCCS consensus guiding principles of the refinement of the concept of VCI.

Mechanisms of cause suggested by VICCCS participants Percentage support Cerebral amyloid angiopathy 93% Mixed forms; any neurodegenerative diseases with CVD (e.g., DLB with CVD) 93% White matter hyperintensities 93% Microbleeds/microhaemorrhages 89% Microinfarcts 89% Arteritis/vasculitis, including both local and systemic inflammatory syndromes 82% Subdural or subarachnoid haemorrhage 70% Option "others" for future developments 67% Venous thromboses/infarcts 63% Infectious vasculitis 53% Hippocampal sclerosis 42% Angiomatous lesions/vascular tumors with local steal phenomenon 33% Chronic migraine 9% Table 1: Clarification of the possible mechanisms of cause of either sporadic or hereditary VCI. Participants were given the opportunity to propose additional causative mechanisms to those previously listed in the O Brien concept 13. Percentage support from respondents in the final round is detailed. Those highlighted in bold italics reached consensus support of 67% and therefore are recommended.

Subtypes in the VICCCS Descriptive terms in the VICCCS O Brien concept classification and causes of sporadic VCI Post stroke dementia Post stroke dementia Vascular dementia Multi-infarct (cortical) Subcortical ischaemic Multi-infarct dementia (cortical vascular dementia) Subcortical ischaemic vascular dementia Strategic infarct Hypoperfusion Haemorrhagic Specific arteriopathies Strategic-infarct dementia Hypoperfusion dementia Haemorrhagic dementia Dementia caused by specific arteriopathies Mixed dementias* Mild VCI Mixed AD and vascular dementia Vascular mild cognitive impairment Vasculitis Table 2: VICCCS recommended subtypes and descriptive terms. Mild VCI, Post stroke dementia, Multi-infarct (cortical), Subcortical ischaemic and Mixed dementias are agreed subtypes in the VICCCS. Those in bold italics fall under the umbrella term Major VCI (VaD). Agreed revised definitions of subtypes are detailed in Box 2. *A revised holistic subtype of Mixed dementias was developed and agreed over the course of number of rounds to replace Mixed AD and VaD. VICCCS agreed descriptive terms include; strategic infarct, hypoperfusion, haemorrhagic and specific arteriopathies. Specific arteriopathies was agreed in a separate question over two rounds to include; genetic, hereditary and developmental anomalies (e.g. Fabry's disease, sickle cell disease, CADASIL, CARASIL), small vessel disease from chronic hypertension and/or diabetes, inflammatory/immunological vasculitis, Moyamoya disease, and intracranial atherosclerosis.

Vasculitis, which was not originally part of the O Brien concept, was also discussed in more detail as being an important descriptive term. The original O Brien concept classification and causes of sporadic vascular cognitive impairment 13 are listed for comparison.

Post-stroke dementia A patient described as having post-stroke dementia (PSD) may or may not have presented evidence of mild cognitive impairment prior to stroke. The patient may exhibit immediate AND/OR delayed cognitive decline that begins after, but within 6 months, of stroke, that does not recover. PSD results from different vascular causes and changes in brain. It includes cases with multiple corticosubcortical infarcts, strategic infarcts, subcortical ischaemic vascular dementia and various forms of neurodegenerative pathology, including AD, which develop within 6 months of stroke*. This temporal basis for cognitive decline after stroke differentiates PSD from other forms of major VCI (VaD). "Mixed dementias" A standalone umbrella subgroup termed "mixed dementias" includes all the phenotypes specified for each combination, i.e. VCI-AD, VCI-DLB etc. It is recommended that a patient is referred to as having VCI-AD, according to the phenotypes present, rather than less specific "mixed dementia", for example. *Where discrimination is possible, the order of terms should reflect the relative contribution of the underlying pathology, i.e. AD-VCI, or VCI- AD. Subcortical ischaemic vascular dementia (SIVaD) Small-vessel disease is the main vascular cause of subcortical ischaemic vascular dementia. Lacunar infarct and ischaemic white-matter lesions are the main type of brain lesions, which are primarily located subcortically. It incorporates the overlapping clinical entities of Binswanger's disease and the lacunar state. Multi-infarct dementia Multi-infarct dementia (MID) relates to the involvement, and likely contribution, of multiple large cortical infarcts in the development of dementia. BOX 2: VICCCS proposed definitions of Major VCI (VaD) subtypes. The above VICCCS definition of PSD is built upon the definition of O Brien and colleagues 13. *Since a key facet of the definition of PSD is a time component of the appearance of decline within 6 months of having a stroke that does not recover, then irrespective of the presence or absence or co-morbid neurodegenerative pathology, the aspect of time should be the primary variable for delineating between

PSD (with or without neurodegenerative pathology which if present should be described) and mixed pathology (where the contributing components are described). In other words PSD and Mixed Dementias could both have mixed pathology but PSD is recognised by its more acute presentation. As part of the efforts in VICCCS to standardise the nomenclature and abbreviations to be used in the future, VICCCS diagnosis participants were asked which abbreviation, from those most commonly used for subcortical ischaemic vascular dementia, should be taken forward. Initially no consensus was reached (SIVaD 36%; SIVD 23%; SiVaD 19%; SiVD 4%, with 18% stating no preference) but in the subsequent round, where participants were asked to choose their preference from the two most favoured abbreviations from Round 4, most support was for SIVaD (65%) and therefore adopted. 99% of respondents asked about this definition in the VICCCS diagnosis study supported this original definition 11 of subcortical ischaemic vascular dementia whilst 92% supported it as a diagnostic category. 76% of respondents stated they would use this term clinically. 69% of VICCCS diagnosis respondents agreed that MID should be a diagnostic category, however opinion was split on the use of this term in the clinical setting, with only 52% in favour of it. There was a consensus (72%) support for the original definition of MID by Hachinski et al 9 MID reflects the traditional view that multiple large cortical infarcts are required for dementia to develop", however the most frequent objection was use of the word required. Therefore, to give opportunity for this objection to be considered, a modified definition was also presented along with the original definition for participants to state their support of in the subsequent round. The modified definition proposed received a consensus support (72%) is that given.

Evidence based studies to support further sub-division of Mild VCI. Develop a more systematic step-wise approach towards sub-typing of patients based on new VICCCS proposed categories of Location, Aetiology, Domains (affected) and Severity. Investigation of factors that determine immediate or delayed onset of VCI in PSD patients and/or Investigation of factors (e.g. time to onset, biomarkers, cognitive parameters) that may better delineate co-morbidity of PSD with other causes of VCI or non-vascular dementias Further elucidation to improve phenotyping of relative contribution of the co-occurring pathology, e.g. AD-VCI, or VCI-AD in mixed dementias; or other neurodegenerative diseases (e.g. Parkinson s disease) or psychiatric disorders that co-present with CVD. Further exploration of the utility and validity of the traditional term multi-infarct dementia as either a specific-subtype of Major VCI (VaD) or as a complementary descriptive term alongside the newly proposed sub-types of Major VCI (VaD) Box 3: Potential areas for future research as proposed directly or identified from responses from the VICCCS.